Scot R. Kimball
Photo
Academic title Professor of Cellular and Molecular Physiology
College College of Medicine
Campuses Penn State Milton S. Hershey Medical Center
Department Cellular and Molecular Physiology
Graduate programs Physiology
Email Phone FAX
  skimball@psu.edu
  717 531 8970
  717 531 7667
Educational background
  Ph.D., University of Vermont College of Medicine, 1983
Postdoctoral Training, Pennsylvania State University College of Medicine, 1982-1985
Research interests
 

Hormonal and Nutritional Regulation of Protein Synthesis in Eukaryotic Cells

The overall goal of the research program is to understand the regulation of the initiation phase of protein synthesis in eukaryotic cells. Of the many steps in initiation, only two have been shown to be subject to regulation in vivo. These steps are the binding of initiator methionyl-tRNAi to the 40S ribosomal subunit and the binding of mRNA to the 43S preinitiation complex. The former step is mediated by a protein termed eukaryotic initiation factor (eIF)-2 and is regulated by changes in the activity of a guanine nucleotide exchange protein, eIF2B, that catalyzes GDP exchange on eIF2. The binding of mRNA to the 43S preinitiation complex involves the interaction among a group of proteins collectively referred to as eIF4F and the binding of the eIF4F complex to the 5'-end of mRNA.

Our previous studies have shown that in rat liver and skeletal muscle, the initiation of protein synthesis is responsive to a variety of stimuli including insulin, essential amino acids, and calcium-mobilizing hormones. In each of these cases, initiation is regulated through changes in the interaction of specific initiation factors with each other and/or with various regulatory proteins. The binding of the initiation factors to each other and to the regulatory proteins is controlled through changes in phosphorylation state. For example, eIF4E is an mRNA cap binding protein important in controlling not only the overall rate of protein synthesis, but also in selecting which mRNAs will be translated into protein. The ability of eIF4E to bind to the mRNA cap structure is regulated by its interaction with a second initiation factor, eIF4G, and the translational regulator, 4E-BP1. In skeletal muscle of diabetic rats, the amount of eIF4E present in the active eIF4F complex is decreased relative to controls whereas the amount in the inactive 4E-BP1·eIF4E complex is increased. The binding of eIF4E to these other proteins is correlated with changes in phosphorylation of each of the proteins. Current efforts are directed at delineating the mechanism of interaction of eIF4E with 4E-BP1 and eIF4G as well as the interaction between eIF2 and eIF2B using biochemical and molecular biological approaches. In addition, the effect of phosphorylation on the activity and interaction of the proteins is being investigated. Finally, identification and characterization of the kinases and phosphatases involved in mediating the changes in phosphorylation state is in progress.

Graphic
  Graphic
  Deletion analysis of the eIF2B binding site on the betat subunit of eIF2. Two deletion mutants of the eIF2beta cDNA were constructed such that the expressed protein was truncated at amino acids 200 (mutant 200) or 268 (mutant 268) as illustrated on the left. Each of the proteins was expressed in Sf9 cells with the modified FLAG epitope (DYKDDDDKID) at the N-terminus. The binding of eIF2B to full-length eIF2beta and the eIF2beta mutants was assessed by a protein interaction assay. In this assay, eIF2B was bound to wells of a microtitre plate and probed with either full-length eIF2beta (wt), eIF2beta truncated amino acid 200 (200), or eIF2beta truncated at amino acid 268 (268). Quantitation of the binding of eIF2beta to eIF2B was assessed using an anti-FLAG monoclonal antibody. A typical SDS-polyacrylamide gel of the mutant 200 (200), mutant 268 (268), and full-length (wt) eIF2beta proteins purified from Sf9 cells is shown in the insert in the right panel. Molecular mass standards are indicated in kilodaltons on the left of the insert.
Areas of expertise
 
Guanine Nucleotide Exchange FactorsProtein Biosynthesis
Calcium SignalingMuscles
MyocardiumMuscular Diseases
SirolimusAlbumins
Adipose TissueGlucagon
GlucocorticoidsLeucine
GlutaminePhosphoric Diester Hydrolases
FoodAdipocytes
Central Nervous System DepressantsDNA, Ribosomal
Protein KinasesHepatitis, Animal
DexamethasoneCyclic AMP
InsulinAmino Acids, Essential
Receptors, GlucocorticoidPoly A
Escherichia coli InfectionsBacteremia
Protein-Serine-Threonine KinasesHistidine
Bacteroides fragilisDNA, Complementary
GluconeogenesisBacteroides Infections
Peptide Chain Initiation, TranslationalLiver
RNA, Double-StrandedCarrier Proteins
Eukaryotic Initiation Factor-2RNA, Messenger
Hypoglycemic AgentsRNA, Ribosomal
Peptide Initiation FactorsPhysical Conditioning, Animal
CyclopentanesExertion
Phosphotransferases (Alcohol Group Acceptor)Eukaryotic Initiation Factor-2B
Ribosomal ProteinsPyrazines
Transcription, GeneticTyrosine
AbscessInsulin-Like Growth Factor I
EthanoleIF-2 Kinase
Ribosomal Protein S6 KinasesProtein Synthesis Inhibitors
VasopressinsSignal Transduction
ProteinsAnimals, Newborn
RibosomesZinc
SepsisMuscle, Skeletal
BrainRepressor Proteins
Microsomes, LiverEating
GuanidinesEndoplasmic Reticulum
Phosphoprotein PhosphatasesSerum Albumin
FibroblastsDiabetes Mellitus, Experimental
Immunosorbent TechniquesLipopolysaccharides
Muscle ProteinsReceptors, Tumor Necrosis Factor
Adenine NucleotidesInfection
CalciumBacterial Infections
Dietary CarbohydratesHormones
RNAAging
Dietary ProteinsGene Expression Regulation
Gene ExpressionHydroquinones
PhosphoproteinsGuanine Nucleotides
Amino AcidsAmino Acids, Branched-Chain
RNA, Transfer, MetCalcium-Calmodulin-Dependent Protein Kinases
Insulin-Like Growth Factor Binding Protein 3Exercise
Aminoimidazole CarboxamideMultienzyme Complexes
RibonucleotidesPyrazoles
PyrimidinesAdaptation, Physiological
GlycineTryptophan
Diabetes MellitusWeight Lifting
DiazoxideInsulin Antagonists
Conserved SequenceMammals
Saccharomyces cerevisiaePsoas Muscles
Fatty Acids, NonesterifiedCytoplasmic Granules
Eukaryotic CellsEukaryotic Initiation Factors
StressEukaryotic Initiation Factor-4G
ApoptosisNeurons
Ribosomal Protein S6 Kinases, 70-kDaAnti-Infective Agents
DNA-Binding ProteinsTranscription Factors
Sarcoplasmic ReticulumRats
AndrogensExtracellular Signal-Regulated MAP Kinases
Mitogen-Activated Protein Kinase KinasesPolycystic Ovary Syndrome
Theca CellsMAP Kinase Kinase 1
Muscle FibersTumor Necrosis Factor-alpha
Energy MetabolismMyocardial Reperfusion Injury
GlucosamineDiabetic Retinopathy
Pancreas, ExocrineAdenylate Kinase
Publication author name
  Kimball SR

also ...
All publications